These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2452946)

  • 1. Studies on the mechanism of the vasodilator action of nicorandil.
    Lefer DJ; Lefer AM
    Life Sci; 1988; 42(19):1907-14. PubMed ID: 2452946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicorandil: differential contribution of K+ channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin.
    Borg C; Mondot S; Mestre M; Cavero I
    J Pharmacol Exp Ther; 1991 Nov; 259(2):526-34. PubMed ID: 1682478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of guanylate cyclase stimulation and K+ channel opening to nicorandil-induced vasorelaxation depends on the conduit vessel and on the nature of the spasmogen.
    Magnon M; Durand I; Cavero I
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1411-8. PubMed ID: 7908056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional differences in the vasorelaxant effects of nicorandil and amlodipine on isolated porcine coronary arteries.
    Tankó LB; Mikkelsen EO; Frøbert O; Bagger JP
    Fundam Clin Pharmacol; 1998; 12(1):50-7. PubMed ID: 9523184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system.
    Cavero I; Pratz J; Mondot S
    Z Kardiol; 1991; 80 Suppl 7():35-41. PubMed ID: 1838848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters.
    Greenberg SS; Cantor E; Ho E; Walega M
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicorandil-induced vasorelaxation: functional evidence for K+ channel-dependent and cyclic GMP-dependent components in a single vascular preparation.
    Meisheri KD; Cipkus-Dubray LA; Hosner JM; Khan SA
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):903-12. PubMed ID: 1714013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
    Fujiwara T; Angus JA
    Br J Pharmacol; 1996 Dec; 119(8):1549-56. PubMed ID: 8982500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanylate cyclase and not ATP-dependent K(+) channels seems temperature-dependent in smooth muscle relaxation of human umbilical arteries.
    Tiritilli A
    Eur J Pharmacol; 2000 Oct; 406(1):79-84. PubMed ID: 11011037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relaxant action of nicorandil in guinea-pig isolated trachealis.
    Allen SL; Foster RW; Morgan GP; Small RC
    Br J Pharmacol; 1986 Jan; 87(1):117-27. PubMed ID: 2420397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasodilation profile of CD-832, a novel dihydropyridine derivative in rabbit aorta.
    Noguchi K; Takahashi K; Araki H; Higuchi S
    Gen Pharmacol; 1997 Sep; 29(3):361-6. PubMed ID: 9378240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the inhibitory effects of nicorandil, nitroglycerin and isosorbide dinitrate on vascular smooth muscle of rabbit aorta.
    Murakami K; Karaki H; Urakawa N
    Eur J Pharmacol; 1987 Sep; 141(2):195-202. PubMed ID: 2445588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive effects of eicosapentaenoic acid on isolated vascular smooth muscle.
    Yanagisawa A; Lefer AM
    Basic Res Cardiol; 1987; 82(2):186-96. PubMed ID: 3038070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Nicotinamidoethyl acetate (SG-209) is a potassium channel opener: structure activity relationship among nicorandil derivatives.
    Ishibashi T; Hamaguchi M; Imai S
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):235-9. PubMed ID: 1658666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological interaction experiments differentiate between glibenclamide-sensitive K+ channels and cyclic GMP as components of vasodilation by nicorandil.
    Holzmann S; Kukovetz WR; Braida C; Pöch G
    Eur J Pharmacol; 1992 Apr; 215(1):1-7. PubMed ID: 1325362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nicorandil on human isolated corpus cavernosum and cavernous artery.
    Hedlund P; Holmquist F; Hedlund H; Andersson KE
    J Urol; 1994 Apr; 151(4):1107-13. PubMed ID: 8126802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery.
    Eltze M
    Eur J Pharmacol; 1989 Jun; 165(2-3):231-9. PubMed ID: 2528466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological mechanisms involved in the vasodilator effects of extracts from Echinodorus grandiflorus.
    Tibiriçá E; Almeida A; Caillleaux S; Pimenta D; Kaplan MA; Lessa MA; Figueiredo MR
    J Ethnopharmacol; 2007 Apr; 111(1):50-5. PubMed ID: 17150321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxing effect of nicorandil (N-2-(hydroxyethyl)-nicotinamide nitrate), a new anti-angina agent, on the isolated vascular smooth muscle.
    Shibata S; Satake N; Takagi T; Kerfoot F; Suh TK
    Eur J Pharmacol; 1984 Mar; 99(2-3):219-26. PubMed ID: 6234181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium channel opening properties of a novel compound, NIP-121, cromakalim and nicorandil in rat aorta and portal vein.
    Masuda Y; Arakawa C; Yamashita T; Miyajima M; Shigenobu K; Kasuya Y; Tanaka S
    Eur J Pharmacol; 1991 Apr; 195(3):323-31. PubMed ID: 1831135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.